Barbiturates: Central Nervous System Depressants

Barbiturates are CNS depressants that enhance GABAA receptor-mediated chloride influx, causing sedation, hypnosis, anesthesia, and at high doses, respiratory depression.

Historical Use

1900s–1960s: Sedatives, hypnotics, anticonvulsants, anesthesia induction.

Decline

  • Narrow therapeutic index (lethal dose close to therapeutic).
  • High physical dependence and withdrawal severity (seizures, delirium).
  • Dangerous interactions with alcohol/opioids.
  • Enzyme induction alters metabolism of other drugs.

Current Role

  • Refractory status epilepticus (pentobarbital, thiopental).
  • Neurocritical care: controlled coma for intracranial hypertension.
  • Physician-assisted death (where legal: secobarbital, pentobarbital).

Replacements

Benzodiazepines (wider safety margin), Z-drugs, newer antiseizure medications.

Barbiturates remain a cautionary example of iatrogenic harm from inadequate safety profiling.

Drug Addiction - Related Articles